臨床試驗

YAG Laser Vitreolysis for Vitreous Floaters

NCT：NCT06915922 · COMPLETED

NCT IDNCT06915922

狀態COMPLETED

開始日期2023-10-17

完成時間2026-08-13

SponsorVMR Consulting, Inc. (OTHER)

First posted2025-04-08

Last updated2026-09-11

簡要摘要

The purpose of this study is to measure how the quality of life, the structure of eye, and vision change after treatment for the opacities in the gel (vitreous) that fills the center of eye which cause vision disturbances commonly called "floaters". In this study the vitreous floaters are treated using a Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser. The FDA has approved the use of this laser to treat membranes in the eye.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。